PacBio’s mission is to enable the promise of genomics to better human health.
We create some of the world’s most advanced sequencing technologies to provide scientists and clinical researchers the insights to better understand biology and health.
Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing technology and our emerging short read Sequencing by Binding (SBB®) technology. Our products address solutions across a broad set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Recent and Upcoming Events
2022 Annual Meeting of Stockholders
May 25, 2022
at 9:00 AM PDT
BofA Securities 2022 Healthcare Conference
May 12, 2022
at 11:20 AM PDT
Pacific Biosciences of California, Inc. First Quarter 2022 Earnings Conference Call
May 4, 2022
at 5:00 PM EDT